Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Synageva BioPharma Corp

+ Add to Watchlist

GEVA:US

104.7300 USD 1.2200 1.18%

As of 20:10:00 ET on 04/20/2015.

Snapshot for Synageva BioPharma Corp (GEVA)

Open: 103.9600 Day's Range: 101.2300 - 106.0300 Volume: 222,029
Previous Close: 103.5100 52wk Range: 60.1900 - 122.8800 1-Yr Rtn: +32.74%

Stock Chart for GEVA

No chart data available.
  • GEVA:US 104.6100
  • 1D
  • 1M
  • 1Y
103.5100
Interactive GEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GEVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -5.8700
Est. EPS (USD) (12/2015) -7.5420
Est. PEG Ratio -
Market Cap (M USD) 3,870.64
Shares Outstanding (M) 36.96
30 Day Average Volume 316,552
Price/Book (mrq) 7.3849
Price/Sale (ttm) 527.2056
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 5.0000
Dividend Ex-Date 12/30/2008
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GEVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GEVA

Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Sanj K PatelPresident/CEORobert Bazemore "Rob"Chief Operating Officer
Carsten BoessSenior VP/CFOGlen WilliamsSenior VP:Global Technical Ops
More Company Profile & Key Executives for GEVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil